News | March 15, 2023
Cepheid launches its first manufacturing unit in India
The facility has been set up to manufacture tuberculosis testing cartridges
The facility has been set up to manufacture tuberculosis testing cartridges
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
The expansion in Indore is well-aligned with Lupin Diagnostics’ commitment to improving access to high-quality, reliable, and advanced testing centres and home collection facilities at an affordable price
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
Expanding diagnostics footprint in East India
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
Subscribe To Our Newsletter & Stay Updated
